Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

36
Ford, Starbucks, Under Armour and More Major Earnings Coming This Week

17h 247wallst
We are now in the heart of the second-quarter earnings reporting season, with perhaps the busiest week of the season on deck. Most of the companies in the S&P 500 will be reporting this week and will most definitely set a direction for the markets. With this season also comes high expectations, as the Nasdaq and S&P 500 have risen recently to near all-time highs. This earnings season will be driven by some of the biggest companies in the United States, but they have to hit their targets first if the markets want to keep up their momentum.
HAL F UAA MA PYPL HOG SYF UA MAT HAS GM.WS.A GM.WS.B GM.WS.C TRI SBUX GM GM.WSB

9
WSJ: Look who’s getting Apple, Starbucks stock

2018-07-21 247wallst
From Apple, Starbucks Have an Answer for the Tight Job Market in Saturday’s Wall Street Journal ($):
AAPL SBUX

42
The 'Making Money While I Sleep' Portfolio - Introduction And July Purchases

2018-07-20 seekingalpha
"If you don't find a way to make money while you sleep, you will work until you die." - Warren Buffett.
JD BABA FB SHW V AAPL SBUX GOOG BIDU

44
How Uncertainty Kills Commerce

2018-07-20 seekingalpha
Both species, a new study conducted by researchers at the University of Minnesota Medical School has found, express profound regret over how much time is spent waiting for something to happen. The study examined the behaviors of humans and mice before each was given an option to wait and receive reward (food for mice, videos for humans) and then after making the commitment while waiting to receive it.
AMZN SBUX WMT

7
Starbucks Signing Store: Deaf-Friendly Store to Open in D.C.

2018-07-20 investorplace
The first Starbucks signing store in the U.S. will be opening its doors to customers later this year.
SBUX

32
Top Research Reports for Microsoft, Novartis & Goldman Sachs

2018-07-20 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Novartis (NVS) and Goldman Sachs (GS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP HD NTRSP KMI.WS WFC.PRL WAFDW WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ KMI.PRA WFC.PRP KMI NTRS WFC.PRO GM.WS.A WFC.PRN GM.WS.B GM.WS.C WAFD GM WFC.PRY WFC.PRX KMR CVB WFC.PRW WFC.PRV WFC WFC.WS ROST NVS MSFT SBUX GM.WSB KMRFZ

7
This Company Has Potential, But Must Produce More Cash Flow

2018-07-20 seekingalpha
Assuming that free cash flow growth increased to 20% per year starting from 2021, then the five-year upside for this company still looks favourable.
SBUX

7
Apple, Starbucks Have an Answer for the Tight Job Market: Hand Out Stock - WSJ

2018-07-20 wsj
U.S. companies are collecting record amounts of cash in their coffers, and many can’t think of anything better to do with it than buy back their stock. Here’s a better idea: Hand out some of those shares to rank-and-file employees.
SBUX

7
Starbucks to Open First of Its Kind Signing Store in the US

2018-07-20 247wallst
Starbucks Corp. (NASDAQ: SBUX) recently announced that it will be opening its first “Signing Store” in the United States, specifically in Washington D.C. This new store will be manned by a team of deaf Starbucks partners (employees), and allies led an effort to launch this unique store model. The store is expected to open in early October.
SBUX

34
My Dividend Growth Portfolio - Q2 2018 Summary

2018-07-19 seekingalpha
I believe that someone who writes about financial assets should share his main holdings with his readers.
LMT FB GD GIS TXN XOM TWX UTX GOOG KMB K TWC GOOGL AAPL KHC SBUX ABBV MSFT ADM OHI MMP PFE ABBV

37
Restaurant Brands International Brings Tim Horton’s to China

2018-07-19 investorplace
Imagine, Canadian coffee on the streets of Beijing. Imagine 1,500 stores competing directly with Starbucks Corp. (NASDAQ:SBUX) and its planned 5,000 store network. Imagine Chinese going around wearing beanies and talking about hockey.
BRK.A KHC SBUX QSR MCD QSR.WI ABEV

7
Starbucks to open first U.S. store designed to service the deaf and hard of hearing - MarketWatch

2018-07-19 marketwatch
Starbucks Corp. SBUX, +0.06% said Thursday that it will open a cafe in October that caters to the needs of the deaf and hard of hearing. All of the associates in the new Washington D.C. store, about 20 to 25, will be fluent in American Sign Language (ASL). The idea for the store came from the Starbucks Signing Store in Kuala Lumpur, Malaysia, which opened in 2016 with nine deaf workers. Starbucks shares are down 0.
SBUX

22
RPT-Microsoft's focus on cloud, partnerships paying off

2018-07-19 reuters
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp, a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

21
Microsoft's focus on cloud, partnerships paying off - Channel NewsAsia

2018-07-18 channelnewsasia
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp , a partnership that illustrates how Microsoft's chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to SBUX / Starbucks Corp. on message board site Silicon Investor.

Starbucks (SBUX) Coffee Shop
Starbucks Starbucks SBUX
CUSIP: 855244109